Trump tariff
Drugmakers Push US Expansion After Trump’s 100% Pharma Tariff Threat
Trump tariff; pharmaceuticals; US manufacturing; branded drugs; drugmakers; Genentech; Roche; Novo Nordisk; Section 232; supply chain
Actionable Insights Powered by AI
Trump tariff; pharmaceuticals; US manufacturing; branded drugs; drugmakers; Genentech; Roche; Novo Nordisk; Section 232; supply chain